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Relationship Between Blood Plasma and Synovial Fluid
Metabolite Concentrations in Patients with
Osteoarthritis
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ABSTRACT. Objective. To investigate the relationship between plasma and synovial fluid (SF) metabolite concen-
trations in patients with osteoarthritis (OA). 
Methods. Blood plasma and SF samples were collected from patients with primary knee OA under-
going total knee arthroplasty. Metabolic profiling was performed by electrospray ionization tandem
mass spectrometry using the AbsoluteIDQ kit. The profiling yielded 168 metabolite concentrations.
Correlation analysis between SF and plasma metabolite concentrations was done on absolute concen-
trations as well as metabolite concentration ratios using Spearman’s rank correlation (r)  method. 
Results.A total of 69 patients with knee OA were included, 30 men and 39 women, with an average
age of 66 ± 8 years. For the absolute metabolite concentrations, the average r was 0.23 ± 0.13. Only
8 out of 168 metabolite concentrations had a r ≥ 0.45, with a p value ≤ 2.98 × 10-4, statistically signifi -
cant after correcting multiple testing with the Bonferroni method. For the metabolite ratios (n =
28,056), the average r was 0.29 ± 0.20. There were 4018 metabolite ratios with a r ≥ 0.52 and a p
value ≤ 1.78 × 10-6, significant after correcting multiple testing. Sex-separate analyses found no
difference in r between men and women. Similarly, there was no difference in r between people
younger and older than 65 years. 
Conclusion. Correlation between blood plasma and SF metabolite concentrations are modest.
Metabolite ratios, which are considered proxies for enzymatic reaction rates and have higher corre-
lations, should be considered when using blood plasma as a surrogate of SF in OA biomarker identi-
fication. (J Rheumatol First Release March 1 2015; doi:10.3899/jrheum.141252)
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Metabolomics has become an ideal method for osteoarthritis
(OA) biomarker identification1. A range of biological
samples can be used for metabolomics studies, such as
plasma, urine, tissue, and other body fluids. Each provides
different information with particular strengths and weak -
nesses2. The selection of sample sources is largely dependent
on study questions and sample availability3. Research has
shown that more subtle biochemical changes occurred in the
earliest stages of OA progression, and altered composition or
concentrations of synovial fluid (SF) components are directly
linked to OA4. SF is an ideal specimen for OA studies
because the metabolite concentrations in SF can directly
reflect the biological process of cartilage and other joint
tissues. However, obtaining SF samples is invasive and not
practical in a clinical setting. Thus, one of the most frequently
used biological samples in OA research is blood, under the
assumption that plasma metabolic components can indirectly
reflect biological processes in a joint. The assumption 
has been tested on only a few carbohydrates and pep -
tides/proteins5,6,7,8. More comprehensive investigations are
needed. Therefore, we undertook this study to systematically
examine the relationship between plasma and SF metabolite
concentrations in patients with OA.
MATERIALS AND METHODS
Patients. Our study was part of the Newfoundland Osteoarthritis Study9.
Patients with OA were recruited from those who underwent total knee
replacement surgery owing to primary OA between November 2011 and
December 2013 in St. Clare’s Mercy Hospital and Health Science Centre
General Hospital in St. John’s, the capital of Newfoundland and Labrador,
Canada. The study was approved by the Health Research Ethics Authority
of Newfoundland and Labrador and written consent was obtained from all
the participants. Demographic and medical information was collected by a
self-administered general questionnaire with the assistance of research staff
if necessary.
Metabolic profiling. Blood samples were collected after at least 8 h of
fasting, and plasma was separated from the whole blood using a standard
protocol. SF samples were collected during joint surgeries. Prior to knee
arthrotomy, a syringe was inserted into the suprapatellar pouch of the knee,
and 2–4 ml of SF was aspirated. The samples were then put in vials and
stored in liquid nitrogen until analysis. Plasma samples were separated from
the whole blood samples using a standard protocol and the SF samples were
processed based on the instruction of the metabolomics assay kit (Biocrates
Life Sciences AG). Metabolic profiling was performed on the Waters XEVO
TQ MS system (Waters Ltd.) using the Biocrates AbsoluteIDQ p180 kit,
which measures 186 metabolites including 90 glycerophospholipids, 40
acylcarnitines (1 free carnitine), 21 amino acids, 19 biogenic amines, 15
sphingolipids, and 1 hexose (> 90% is glucose). The details of the 186
metabolites are listed in Supplementary Table 1, available online at
jrheum.org. The metabolic profiling method using this kit has been
described1. 
Statistical methods. Metabolite concentrations in plasma and SF samples
were obtained. The metabolites present in at least 80% of samples were used
for analysis10 and the missing values were replaced by half of the minimum
value found in the dataset11. The ratios of the pairwise metabolite concen-
trations (168 × 167 = 28,056 ratios) as proxies for enzymatic reaction rates
were calculated. Spearman’s rank correlation coefficient (r) was used to
determine the relationship for each metabolite concentration and metabolite
ratio between plasma and SF. Statistical analysis was carried out using PCIT
package implemented in R (version 3.1.1 for Windows). Bonferroni method
was used to correct multiple testing. Significance level was defined as p
value ≤ 2.98 × 10-4 (0.05/168) for metabolites and p value ≤ 1.78 × 10-6
(0.05/28056) for metabolite ratios to control type I error. The correlation
analysis was also performed in men and women, separately, as well as people
younger and older than 65 years. The results were also confirmed by
split-analysis. 
RESULTS
A total of 30 male and 39 female patients with knee OA were
included in the study. Mean age of participants was 66 ± 8
years, and the mean body mass index was 33.3 ± 6.9 kg/m2. 
Over 90% of the targeted metabolites (168/186) were
successfully determined in each sample. These included 40
acylcarnitines (including free carnitine), 20 amino acids, 9
biogenic amines, 87 glycerophospholipids, 11 sphingolipids,
and 1 hexose (> 90% glucose). 
For each of the 168 metabolites, the Spearman’s rank
correlation coefficient (r) between plasma and SF ranged
from –0.12 to 0.59, and 90% of the relationships were
positive. The average r for all relationships was 0.23 ± 0.13.
Only 8 out of 168 metabolites had r ≥ 0.45 with p ≤ 2.98 ×
10-4. These 8 metabolites were 4 amino acids (glycine,
leucine, valine, and isoleucine), 3 glycerophospholipids
(phosphatidylcholine diacyl C36:0, phosphatidylcholine acyl-
alkyl C30:0, phosphatidylcholine diacyl C24:0), and
creatinine (Figure 1). The r for all the metabolite concentra-
tions is provided in Supplementary Table 2, available online
at jrheum.org. When we examined the correlation separately
for men and women, we found that on average men tended
to have a higher r (0.32 ± 0.25) than women (0.21 ± 0.16),
but this difference was not statistically significant. Similarly,
there was no difference in r between people younger and
older than 65 years, and the average r was 0.22 ± 0.16 and
0.23 ± 0.17, respectively. 
For the 28,056 (168 × 167) pairwise metabolite concen-
tration ratios, r ranged from –0.33 to 0.85. The average r
was 0.29 ± 0.20, and 92% were positive. There were 4018
metabolite ratios with r ≥ 0.52 and p < 1.78 × 10-6, of which
66 metabolite ratios had r ≥ 0.8 (Table 1). The r for all the
metabolite ratios is provided in Supplementary Table 3,
available online at jrheum.org. Similar correlations were
observed for men (mean r = 0.27 ± 0.27) and women (mean
r = 0.29 ± 0.20), as well as for people younger and older than
65 years (mean r = 0.27 ± 0.21 and 0.29 ± 0.23, respectively). 
Split-half analyses in which the whole sample was
randomly divided into 2 parts were used to confirm the
results. For the 168 absolute concentrations, the average r
values in 2 parts were 0.20 ± 0.13 and 0.19 ± 0.17, respec-
tively. For the 28,056 metabolite ratios, the average r values
in 2 parts were 0.25 ± 0.26 and 0.30 ± 0.20, respectively. 
Metabolite ratios had consistent correlations in 2
subsamples whereas large discrepancies were observed for
some of the metabolite concentrations. For 4018 significant
metabolite ratios, the average absolute difference in r values
between 2 subsamples was 0.13, and 86% of the metabolite
ratios had a difference of < 0.25. For the 8 significant metabo-
lites, the average absolute difference in r values between 2
subsamples was 0.29. The most consistent correlation was
for isoleucine with virtually the same r in 2 subsamples.
Creatinine was the one with the largest discrepancy, with a r
of 0.6 in the first half samples and no correlation in the other
half samples. 
DISCUSSION
Although blood plasma samples have been used in OA
research under the assumption that plasma components could
indirectly reflect joint biological processes12,13, to the best of
our knowledge, this is the first study that systematically
examined the relationship between plasma and SF metabolite
concentrations in patients with OA.
Our results documented that all 168 metabolites examined
can be detected in both blood plasma and SF, adding evidence
to support the assumption. However, we found that metabolite
concentrations in plasma and SF vary substantially. The
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Table 1. Highly correlated metabolite ratios with r ≥ 0.8 (n = 66).
Metabolites Metabolite Ratios (mean ± SD ) r
Numerator Denominator Synovial Plasma 
PC aa C36:3 PC aa C38:5 2.12 ± 0.44 2.43 ± 0.58 0.85 
PC aa C38:5 PC aa C36:3 0.49 ± 0.10 0.43 ± 0.11 0.85 
PC aa C34:2 PC aa C36:4 1.5 ± 0.39 1.74 ± 0.53 0.85 
PC aa C36:4 PC aa C34:2 0.71 ± 0.21 0.62 ± 0.19 0.85 
PC ae C38:2 PC ae C44:5 3.34 ± 0.87 3.98 ± 1.31 0.84 
PC ae C44:5 PC ae C38:2 0.31 ± 0.08 0.27 ± 0.08 0.84 
PC aa C38:4 PC ae C36:2 18.89 ± 5.62 15.12 ± 6.08 0.84 
PC ae C36:2 PC aa C38:4 0.05 ± 0.01 0.07 ± 0.02 0.84 
SM (OH) C14:1 SM C16:0 0.03 ± 0.01 0.04 ± 0.01 0.84 
SM C16:0 SM (OH) C14:1 26.32 ± 5.79 25.44 ± 5.32 0.84 
PC ae C38:2 PC ae C38:4 0.42 ± 0.08 0.45 ± 0.09 0.84 
PC ae C38:4 PC ae C38:2 2.44 ± 0.52 2.26 ± 0.46 0.84 
PC ae C38:3 PC ae C44:5 3.39 ± 0.88 4.31 ± 1.43 0.83 
PC ae C44:5 PC ae C38:3 0.31 ± 0.08 0.25 ± 0.08 0.83 
PC ae C36:2 PC ae C44:5 4.67 ± 1.29 6.74 ± 2.54 0.83 
PC ae C44:5 PC ae C36:2 0.23 ± 0.06 0.16 ± 0.05 0.83 
PC ae C36:1 PC ae C44:5 5.35 ± 1.32 6.99 ± 2.39 0.83 
PC ae C44:5 PC ae C36:1 0.19 ± 0.05 0.15 ± 0.05 0.83 
PC aa C38:4 PC ae C40:6 33.12 ± 7.86 33 ± 11.39 0.82 
PC ae C40:6 PC aa C38:4 0.03 ± 0.01 0.03 ± 0.01 0.82 
PC aa C36:2 PC aa C38:4 1.42 ± 0.36 1.79 ± 0.57 0.82 
PC aa C38:4 PC aa C36:2 0.75 ± 0.21 0.61 ± 0.19 0.82 
PC aa C36:4 PC ae C36:2 23.84 ± 7.76 27.09 ± 10.29 0.82 
PC ae C36:2 PC aa C36:4 0.04 ± 0.01 0.04 ± 0.01 0.82 
PC ae C38:4 PC ae C40:6 3.1 ± 0.56 3 ± 0.59 0.82 
PC ae C40:6 PC ae C38:4 0.33 ± 0.06 0.34 ± 0.06 0.82 
PC aa C38:4 PC ae C38:1 27.11 ± 6.59 26.9 ± 8.7 0.82 
PC ae C38:1 PC aa C38:4 0.03 ± 0.01 0.04 ± 0.01 0.82 
PC aa C38:3 PC aa C38:5 1.22 ± 0.27 1.1 ± 0.27 0.82 
PC aa C38:5 PC aa C38:3 0.85 ± 0.19 0.96 ± 0.25 0.82 
PC ae C38:4 PC ae C44:5 7.92 ± 1.64 8.65 ± 2.10 0.81 
PC ae C44:5 PC ae C38:4 0.13 ± 0.02 0.12 ± 0.02 0.81 
PC aa C38:6 SM C18:0 2.75 ± 1.15 3.83 ± 1.41 0.81 
SM C18:0 PC aa C38:6 0.42 ± 0.17 0.29 ± 0.12 0.81 
PC aa C36:4 SM C20:2 160.25 ± 70.35 153.0 ± 67.3 0.81 
SM C20:2 PC aa C36:4 0.01 ± 0.01 0.01 ± 0.01 0.81 
PC ae C40:6 PC ae C44:5 2.60 ± 0.60 2.97 ± 0.85 0.81 
PC ae C44:5 PC ae C40:6 0.4 ± 0.09 0.36 ± 0.10 0.81 
PC aa C32:3 PC aa C38:6 0.03 ± 0.01 0.02 ± 0.01 0.81 
PC aa C38:6 PC aa C32:3 31.6 ± 15.32 45 ± 20.71 0.81 
PC ae C38:5 PC ae C44:5 12.16 ± 2.41 11.96 ± 3.07 0.81 
PC ae C44:5 PC ae C38:5 0.08 ± 0.01 0.08 ± 0.02 0.81 
PC ae C38:1 PC ae C44:5 3.2 ± 0.82 3.64 ± 1.19 0.81 
PC ae C44:5 PC ae C38:1 0.33 ± 0.08 0.3 ± 0.09 0.81 
SM (OH) C14:1 SM C16:1 0.26 ± 0.05 0.28 ± 0.05 0.81 
SM C16:1 SM (OH) C14:1 3.92 ± 0.80 3.67 ± 0.75 0.81 
PC aa C38:4 PC aa C38:6 2.95 ± 1.01 1.86 ± 0.72 0.81 
PC aa C38:6 PC aa C38:4 0.37 ± 0.13 0.61 ± 0.23 0.81 
PC aa C36:3 PC aa C36:4 0.65 ± 0.16 0.61 ± 0.18 0.81 
PC aa C36:4 PC aa C36:3 1.62 ± 0.42 1.76 ± 0.54 0.81 
PC aa C38:4 SM C20:2 127.38 ± 54.94 86.14 ± 43.99 0.81 
SM C20:2 PC aa C38:4 0.01 ± 0.01 0.01 ± 0.01 0.81 
PC ae C38:3 PC ae C38:4 0.43 ± 0.08 0.49 ± 0.10 0.81 
PC ae C38:4 PC ae C38:3 2.4 ± 0.48 2.09 ± 0.42 0.81 
PC aa C36:2 PC aa C36:4 1.14 ± 0.32 0.99 ± 0.31 0.80 
PC aa C36:4 PC aa C36:2 0.95 ± 0.30 1.11 ± 0.38 0.80 
PC ae C40:5 PC ae C44:5 2.38 ± 0.41 2.44 ± 0.49 0.80 
PC ae C44:5 PC ae C40:5 0.43 ± 0.07 0.42 ± 0.08 0.80 
PC aa C38:4 PC ae C32:1 35.4 ± 11.68 54.06 ± 19.91 0.80 
PC ae C32:1 PC aa C38:4 0.03 ± 0.01 0.02 ± 0.01 0.80 
PC aa C38:4 PC aa C40:6 5.87 ± 1.64 4.87 ± 1.52 0.80 
PC aa C40:6 PC aa C38:4 0.18 ± 0.05 0.22 ± 0.07 0.80 
PC aa C38:4 PC ae C38:2 26.04 ± 6.86 24.71 ± 8.24 0.80 
PC ae C38:2 PC aa C38:4 0.04 ± 0.01 0.04 ± 0.01 0.80 
PC aa C38:5 PC ae C44:5 32.57 ± 9.83 43.01 ± 16.73 0.80 
PC ae C44:5 PC aa C38:5 0.03 ± 0.01 0.02 ± 0.01 0.80 
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Figure 1. Scatter plots for 8 metabolites with r ≥ 0.45. X axes and Y axes are metabolite concentration Z-scores
in plasma and synovial fluid, respectively. PC: phosphatidylcholine.
correlation in the metabolite concentrations between plasma
and SF is modest, with an average r of 0.23, and only 8 out
of 168 metabolites were significantly correlated with r > 0.45,
raising the question as to whether metabolite levels in plasma
can reflect joint metabolism for the purpose of monitoring
disease progression. Proteomic analyses of SF and plasma in
patients with juvenile arthritis showed similar results in which
a defined subset of 30 proteins had statistically significant
differences between SF and plasma, and distinctive synovial
but not plasma proteome expression patterns separate out
among patient subgroups14. Similarly, Catterall, et al15
measured 12 biomarkers in both serum and SF of patients with
acute knee injury. They found that only 4 biomarkers had a
significant correlation, with correlation coefficients ranging
from 0.5 to 0.8. Cartilage oligomeric matrix protein (COMP)
is one of the most studied OA biomarkers, and increased
serum COMP levels have been associated with OA. However,
serum COMP levels were not correlated with synovial COMP
levels in patients with knee OA (r = 0.005)16. 
The mean r and key pathways for each category of
metabolites are shown in Table 2. Metabolites that show a
strong correlation between blood and SF may suggest
systemic pathways, whereas metabolites that show low corre-
lations but higher concentrations in SF than in blood would
suggest localized metabolism, thus reflecting a joint-specific
process. For example, the metabolites arginine and acetylor-
nithine had lower r values (0.10 and 0.29) but their concen-
trations were higher in SF than in plasma by 2.5-fold and
1.9-fold, respectively. Arginine is a crucial factor for bone
creation because, among other things, it supports the
production of collagen17. Arginine deficiency can be the
cause of osteoporosis, especially in the case of older
women18. Adams, et al13 found in synovial tissue that acety-
lornithine concentration was increased significantly in media
with endstage OA versus early/no OA. Therefore, those
metabolites need to be studied using joint tissues rather than
blood.
However, we found a number of metabolite ratios having
a high correlation (r ≥ 0.52, 4018 ratios) between plasma and
SF. When a pair of metabolites is related to the direct
substrates and products of an enzymatic conversion, respec-
tively, the ratio between their concentrations can be used as
an approximation of the enzymatic activity19. 
Using metabolite ratios reduced the variance and yielded
robust statistical power in genetic association studies20. Our
previous study found that branched-chain amino acid-to-
histidine ratio in serum was associated with knee OA1. The
correlation of branched-chain amino acid-to-histidine ratio
between plasma and SF was 0.56. The results of the current
study suggested that those highly correlated metabolite ratios
in plasma could serve as surrogates for SF metabolism, and
could be used for identifying novel biomarkers and pathways
involved in OA development.
Glycerophospholipids form the essential lipid bilayer of
all biological membranes and are intimately involved in
signal transduction, regulation of membrane trafficking, and
many other membrane-related phenomena21,22. A study by
Hills indicates that alterations in phospholipid composition
and concentrations are associated with the development of
OA23. Phospholipids and enzymes involved in lipid metab-
olism were demonstrated to affect the regulation of the
signaling steps leading to neutrophil activation24,25. In
addition, lysophosphatidylcholine (LPC) plays an important
role in inflammation26. LPC is generated by the hydrolysis
of membrane PC by phospholipase A2, acts as a chemo -
attractant at the sites of inflammation, and promotes the
inflammatory reaction. Fuchs, et al27 showed the PC/LPC
ratio detected in plasma may serve as an indicator of
rheumatic arthritis in early stages. In our current study, we
found 70 PC/LPC ratios had r ≥ 0.52. 
Carnitine and its acyl esters acylcarnitines are essential
compounds for the metabolism of fatty acids. Carnitine
acyltransferases are responsible for the production of acylcar-
nitines, and the value of acylcarnitines/carnitine ratio can
reflect its activity19,28. Carnitine can assist the transport and
metabolism of fatty acyl-CoA from the cytosol to the
mitochondrial matrix, where the enzymes of β-oxidation are
located and fatty acids are oxidized as a major source of
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Table 2. The r and key pathways for each category of metabolites.
Metabolites r Key Pathways
Amino acids (20) 0.29 ± 0.14 Amino acid metabolism, urea-cycle, TCA cycle
Glycerophospholipids (87) 0.26 ± 0.10 Lipid metabolism
Biogenic amines (9) 0.26 ± 0.17 Urea-cycle, amino acid metabolism
Sphingolipids (11) 0.25 ± 0.09 Lipid metabolism
Acylcarnitines (40) 0.12 ± 0.14 Energy metabolism, lipid metabolism
Hexose 0.1 Carbohydrate metabolism
Glycerophospholipids ratios, sphingolipids ratios, 
amino acid ratios 0.6–0.85
Biogenic amines, mixed ratios 0.3–0.6
Carnitines, mixed ratios < 0.3
TCA: tricarboxylic acid.
energy. Based on the ratio of acylcarnitine to carnitine in SF,
the patients with OA could be divided into 2 distinct groups29.
However, the correlation of the ratio between SF and plasma
was low, suggesting it is joint specific. 
There are some caveats. First, all our study participants
were endstage patients with OA, thus the findings might not
be readily generalized to patients with early OA or the general
population. Second, anesthesia as a normal practice in the
surgery could influence vascular and lymphatic permeability
and therefore maybe affect the results obtained. Third,
inflammation could have an effect on vascular permeability
and the observed results. However, the current study is a
paired study, e.g., SF and plasma samples were collected
from the same individuals. Inflammation would influence the
majority, if not all, of the metabolite concentrations in SF and
plasma; thus we would expect to observe a similar correlation
for the majority of the metabolite and metabolite ratios,
which in fact is not the case in our results, suggesting this is
not a big concern. Last, while split-half analyses showed
individual correlations for metabolite ratios were stable and
consistent between 2 subsamples, a large discrepancy
between 2 subsamples was observed for some of the
metabolite concentrations, limiting their generalizability to
other populations. Further studies are required to confirm the
results, particularly for metabolite concentrations. 
Correlation between blood plasma and SF metabolite
concentrations are modest. Metabolite ratios, which are
considered proxies for enzymatic reaction rates and have high
correlations, should be considered when using blood plasma
as a surrogate of SF in OA biomarker identification.  
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